Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid cancer, medullary × cabozantinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 43 Carcinoma, Hepatocellular 12 Neoplasm Metastasis 7 Prostatic Neoplasms 6 Neoplasms 6 Kidney Neoplasms 6 Sarcoma 5 Osteosarcoma 5 Clear-cell metastatic renal cell carcinoma 5 Sarcoma, Ewing 4 Neuroendocrine Tumors 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Carcinoma 4 Brain Neoplasms 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Thyroid Neoplasms 3 Ovarian Neoplasms 3 Melanoma 3 Endometrial Neoplasms 3 Carcinoma, Transitional Cell 3 Carcinoma, Medullary 3 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Recurrence 2 Penile Neoplasms 2

Interventions

3-(3'-adamantan-1-yl-4'-methoxybiphenyl-4-yl)-2-propenoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡